Join today and have your say! It’s FREE!
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon May 20, 2021 10:17am
45 Views
Post# 33237092

RE:RE:Really

RE:RE:Really

Subliminal didn't mention the plant inspection on call Tuesday. Why? Obvious. They did mention that they were waiting for word from fda on a plant inspection on Mar 25th call. Kedrion took an option of 3 months expecting a delay to wait for a decision by FDA and, if not positive, they can simply walk away. Sheesh, it pretty simple. 

and no one will just believe you, Realstocky / Newcamo (same guy), as you have been wrong at  $100 price target, $50 (easy), $30, $20, $15, $11, $8, $6.... when it falls to $1, you will pump an easy $2-$3 ... not too credible, not a great track record and lots of lies. 


realstocky wrote:

Kedrion made the deal, i doubt they have time to waste, believe me the plant is good and they expect a ok from FDA.

 

PLITheOne wrote:

 

As far I know the FDA hasn't approved Ryplasim nor inspected the new plant processing put in place. As far as I am aware this would be very difficult given nobody is at the plant anymore. It's a Ghost town. 

Knowing SALP intent you would quickly understand what the results will be from the FDA. Remember that they want to drive this into the ground and take private!

Ryplasim for $5M, seriously. Why do you think SALP is selling out and all other institutional holders already have? Because they expect approval and revenue? Not!





<< Previous
Bullboard Posts
Next >>